Stacey Dillon
About Stacey Dillon
Stacey Dillon serves as the Vice President of Translational Medicine at Alpine Immune Sciences, Inc., a position she has held since 2021. With a Ph.D. in Immunology from the University of Washington and extensive experience in the field, she has previously worked at ZymoGenetics, Inc. and has contributed significantly to immuno-oncology research.
Current Role at Alpine Immune Sciences
Stacey Dillon serves as the Vice President of Translational Medicine at Alpine Immune Sciences, Inc. since 2021. In this role, she oversees the development and implementation of strategies that bridge preclinical research and clinical applications. Her position is critical in advancing the company's mission to develop innovative immunotherapies. She is based in Seattle, Washington.
Previous Experience at Alpine Immune Sciences
Prior to her current role, Stacey Dillon worked at Alpine Immune Sciences, Inc. as the Senior Director of Translational Sciences from 2016 to 2021. During her five years in this position, she contributed to the company's research initiatives and played a key role in the advancement of its therapeutic programs.
Experience at ZymoGenetics
Stacey Dillon held multiple positions at ZymoGenetics, Inc., a Bristol-Myers Squibb Company. She served as the Director of Immuno-Oncology Discovery from 2011 to 2016, where she led research efforts in immuno-oncology. Prior to that, she was a Principal Scientist at ZymoGenetics from 1999 to 2010, focusing on various scientific projects over her eleven-year tenure.
Educational Background in Immunology
Stacey Dillon earned her Ph.D. in Immunology from the University of Washington, where she studied from 1990 to 1995. Additionally, she completed a Post-Doctoral Fellowship at The Johns Hopkins University from 1996 to 1999, focusing on B cell development and tolerance. Her educational background has provided a strong foundation for her career in translational medicine and immunology.